LENZ Therapeutics (LENZ) Other Working Capital Changes (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly Other Working Capital Changes came in at -$27000.0 in Q1 2026, up 99.93% on a QoQ basis from -$38.7 million in Q4 2023.
LENZ Therapeutics (LENZ) Other Working Capital Changes (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 4 years of Other Working Capital Changes data on file, last reported at -$27000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes changed N/A year-over-year to -$27000.0 in Q1 2026; TTM through Mar 2026 was -$39.2 million, a 2.39% increase from a year earlier, with the FY2023 full-year figure at -$41.4 million, down 654.51% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$27000.0, up from -$38.7 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for LENZ reached as high as $3.0 million in Q3 2022 and fell as low as -$709000.0 in Q4 2024.
- Historically, Other Working Capital Changes has averaged $340764.7 across 5 years, with a median of $200000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 68.16% in 2023 and fell as far as 3094.39% in 2023.
- Year by year, Other Working Capital Changes stood at -$1.2 million in 2022, then slumped by 3094.39% to -$38.7 million in 2023, then jumped by 99.93% to -$27000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$27000.0 in Q1 2026, -$38.7 million in Q4 2023, and -$376000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 341,000.00 |
| Mar 31, 2026 | 341,000.00 |
| Mar 31, 2026 | 341,000.00 |
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | -93,000.00 |
| Sep 30, 2025 | -93,000.00 |
| Sep 30, 2025 | -93,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 996,000.00 |
| Mar 31, 2025 | 996,000.00 |
| Mar 31, 2025 | 996,000.00 |
| Dec 31, 2024 | -709,000.00 |
| Dec 31, 2024 | -709,000.00 |
| Dec 31, 2024 | -709,000.00 |
| Sep 30, 2024 | 285,000.00 |
| Sep 30, 2024 | 285,000.00 |